Literature DB >> 31434734

The HIV-1 Antisense Protein ASP Is a Transmembrane Protein of the Cell Surface and an Integral Protein of the Viral Envelope.

Yvonne Affram1, Juan C Zapata1, Zahra Gholizadeh1, William D Tolbert1, Wei Zhou1, Maria D Iglesias-Ussel1, Marzena Pazgier1, Krishanu Ray1, Olga S Latinovic1, Fabio Romerio2.   

Abstract

The negative strand of HIV-1 encodes a highly hydrophobic antisense protein (ASP) with no known homologs. The presence of humoral and cellular immune responses to ASP in HIV-1 patients indicates that ASP is expressed in vivo, but its role in HIV-1 replication remains unknown. We investigated ASP expression in multiple chronically infected myeloid and lymphoid cell lines using an anti-ASP monoclonal antibody (324.6) in combination with flow cytometry and microscopy approaches. At baseline and in the absence of stimuli, ASP shows polarized subnuclear distribution, preferentially in areas with low content of suppressive epigenetic marks. However, following treatment with phorbol 12-myristate 13-acetate (PMA), ASP translocates to the cytoplasm and is detectable on the cell surface, even in the absence of membrane permeabilization, indicating that 324.6 recognizes an ASP epitope that is exposed extracellularly. Further, surface staining with 324.6 and anti-gp120 antibodies showed that ASP and gp120 colocalize, suggesting that ASP might become incorporated in the membranes of budding virions. Indeed, fluorescence correlation spectroscopy studies showed binding of 324.6 to cell-free HIV-1 particles. Moreover, 324.6 was able to capture and retain HIV-1 virions with efficiency similar to that of the anti-gp120 antibody VRC01. Our studies indicate that ASP is an integral protein of the plasma membranes of chronically infected cells stimulated with PMA, and upon viral budding, ASP becomes a structural protein of the HIV-1 envelope. These results may provide leads to investigate the possible role of ASP in the virus replication cycle and suggest that ASP may represent a new therapeutic or vaccine target.IMPORTANCE The HIV-1 genome contains a gene expressed in the opposite, or antisense, direction to all other genes. The protein product of this antisense gene, called ASP, is poorly characterized, and its role in viral replication remains unknown. We provide evidence that the antisense protein, ASP, of HIV-1 is found within the cell nucleus in unstimulated cells. In addition, we show that after PMA treatment, ASP exits the nucleus and localizes on the cell membrane. Moreover, we demonstrate that ASP is present on the surfaces of viral particles. Altogether, our studies identify ASP as a new structural component of HIV-1 and show that ASP is an accessory protein that promotes viral replication. The presence of ASP on the surfaces of both infected cells and viral particles might be exploited therapeutically.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; antisense protein ASP; cell surface protein; viral envelope protein

Mesh:

Substances:

Year:  2019        PMID: 31434734      PMCID: PMC6803264          DOI: 10.1128/JVI.00574-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.

Authors:  Christoph T Berger; Anuska Llano; Jonathan M Carlson; Zabrina L Brumme; Mark A Brockman; Samandhy Cedeño; P Richard Harrigan; Daniel E Kaufmann; David Heckerman; Andreas Meyerhans; Christian Brander
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 2.  Autophagy and MHC-restricted antigen presentation.

Authors:  Jan Valečka; Catarina R Almeida; Bing Su; Philippe Pierre; Evelina Gatti
Journal:  Mol Immunol       Date:  2018-05-19       Impact factor: 4.407

3.  An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription.

Authors:  Sheena Saayman; Amanda Ackley; Anne-Marie W Turner; Marylinda Famiglietti; Alberto Bosque; Matthew Clemson; Vicente Planelles; Kevin V Morris
Journal:  Mol Ther       Date:  2014-02-28       Impact factor: 11.454

4.  Antigenic properties of the HIV envelope on virions in solution.

Authors:  Krishanu Ray; Meron Mengistu; Lei Yu; George K Lewis; Joseph R Lakowicz; Anthony L DeVico
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

5.  Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages.

Authors:  George B Kyei; Christina Dinkins; Alexander S Davis; Esteban Roberts; Sudha B Singh; Chunsheng Dong; Li Wu; Eiki Kominami; Takashi Ueno; Akitsugu Yamamoto; Maurizio Federico; Antonito Panganiban; Isabelle Vergne; Vojo Deretic
Journal:  J Cell Biol       Date:  2009-07-27       Impact factor: 10.539

6.  Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic.

Authors:  Elodie Cassan; Anne-Muriel Arigon-Chifolleau; Jean-Michel Mesnard; Antoine Gross; Olivier Gascuel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

7.  Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.

Authors:  Michael Worobey; Marlea Gemmel; Dirk E Teuwen; Tamara Haselkorn; Kevin Kunstman; Michael Bunce; Jean-Jacques Muyembe; Jean-Marie M Kabongo; Raphaël M Kalengayi; Eric Van Marck; M Thomas P Gilbert; Steven M Wolinsky
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

8.  Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.

Authors:  Christina Guzzo; David Ichikawa; Chung Park; Damilola Phillips; Qingbo Liu; Peng Zhang; Alice Kwon; Huiyi Miao; Jacky Lu; Catherine Rehm; James Arthos; Claudia Cicala; Myron S Cohen; Anthony S Fauci; John H Kehrl; Paolo Lusso
Journal:  Sci Immunol       Date:  2017-05-12

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.

Authors:  William M Switzer; Marco Salemi; Shoukat H Qari; Hongwei Jia; Rebecca R Gray; Aris Katzourakis; Susan J Marriott; Kendle N Pryor; Nathan D Wolfe; Donald S Burke; Thomas M Folks; Walid Heneine
Journal:  Retrovirology       Date:  2009-02-02       Impact factor: 4.602

View more
  14 in total

1.  Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research.

Authors:  Triana Rivera-Megias; Nhut M Le; Alonso Heredia
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Defective HIV-1 genomes and their potential impact on HIV pathogenesis.

Authors:  Jeffrey Kuniholm; Carolyn Coote; Andrew J Henderson
Journal:  Retrovirology       Date:  2022-06-28       Impact factor: 3.768

3.  Identification and mapping of post-transcriptional modifications on the HIV-1 antisense transcript Ast in human cells.

Authors:  Mariana Estevez; Rui Li; Biplab Paul; Kaveh Daneshvar; Alan C Mullen; Fabio Romerio; Balasubrahmanyam Addepalli
Journal:  RNA       Date:  2022-02-15       Impact factor: 5.636

4.  Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Kazuya Shimura; Keiko Takemoto; Miho Watanabe; Masayuki Amano; Hirotomo Nakata; Benquan Liu; Xiaorui Zuo; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

Review 5.  HIV-1 Natural Antisense Transcription and Its Role in Viral Persistence.

Authors:  Rui Li; Rachel Sklutuis; Jennifer L Groebner; Fabio Romerio
Journal:  Viruses       Date:  2021-04-29       Impact factor: 5.048

6.  Origin, Evolution and Stability of Overlapping Genes in Viruses: A Systematic Review.

Authors:  Angelo Pavesi
Journal:  Genes (Basel)       Date:  2021-05-26       Impact factor: 4.096

Review 7.  Long Non-coding RNAs Mechanisms of Action in HIV-1 Modulation and the Identification of Novel Therapeutic Targets.

Authors:  Roslyn M Ray; Kevin V Morris
Journal:  Noncoding RNA       Date:  2020-03-13

8.  Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.

Authors:  Chase W Nelson; Zachary Ardern; Tony L Goldberg; Chen Meng; Chen-Hao Kuo; Christina Ludwig; Sergios-Orestis Kolokotronis; Xinzhu Wei
Journal:  Elife       Date:  2020-10-01       Impact factor: 8.140

9.  OLGenie: Estimating Natural Selection to Predict Functional Overlapping Genes.

Authors:  Chase W Nelson; Zachary Ardern; Xinzhu Wei
Journal:  Mol Biol Evol       Date:  2020-08-01       Impact factor: 16.240

Review 10.  Block and Lock HIV Cure Strategies to Control the Latent Reservoir.

Authors:  Chantelle L Ahlenstiel; Geoff Symonds; Stephen J Kent; Anthony D Kelleher
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.